Concepedia

A. A. van der Veldt

AA

4

Publications

272

Citations

4

H-Index

2009

Active since

Affiliations

Isala(Current)

The Netherlands Cancer Institute

Radboud University Medical Center

Leiden University Medical Center

Radboud University Nijmegen

A. A. van der Veldt is an author at Isala specializing in biomarkers, urology, and medicine.

Top concepts

Publications per year

2009–2024

4

Publications

4

Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity

Nielka P. van Erp, Karel Eechoute, A. A. van der Veldt et al. · Journal of Clinical Oncology · 2009 · 183 citations

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial

Kalijn F. Bol, Gerty Schreibelt, Martine Bloemendal et al. · Nature Communications · 2024 · 35 citations · Full text

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls

Annelies H. Boekhout, Anne Rogiers, Katarzyna Jóźwiak et al. · Acta Oncologica · 2020 · 30 citations · Full text

Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients

Joost S.P. Vermaat, Frank L. Gerritse, A. A. van der Veldt et al. · European Urology · 2012 · 24 citations

, , +10

Rows per page

1–4 of 4